<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03329781</url>
  </required_header>
  <id_info>
    <org_study_id>200130089</org_study_id>
    <nct_id>NCT03329781</nct_id>
  </id_info>
  <brief_title>ENDOCUR - Modulation of Endotoxaemia Via Curcumin Intake in Healthy Overweight Adults</brief_title>
  <acronym>ENDOCUR</acronym>
  <official_title>Modulation of Endotoxaemia Via Curcumin Intake in Healthy Overweight Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Glasgow</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Glasgow</source>
  <brief_summary>
    <textblock>
      Chronic diseases such as diabetes, cardiovascular diseases and cancer are a major burden on
      the Scottish population. Obesity and inflammation have strong links to these diseases. One of
      the mechanisms explaining the relationship between low-grade inflammation and excess weight
      is &quot;endotoxaemia&quot;. We wish to study this phenomenon, when small components coming from our
      gut bacteria can pass into the bloodstream, raising the body's defences. Diet can modulate
      endotoxaemia. In this study, we propose to use curcumin, in a capsule form, to modulate
      endotoxaemia. Curcumin comes from turmeric, which is widely used as a spice. In this study,
      we want to test the effect of consuming curcumin extract to the composition of the gut
      microbiota, post-meal endotoxaemia, and inflammatory markers in blood.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 2015</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of endotoxin in plasma.</measure>
    <time_frame>21 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>Trial</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>350 mg of BCM-95, 1 capsule per day, for 21 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>350 mg of starch, 1 capsule per day, for 21 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>BCM-95</intervention_name>
    <description>Consuming 1 capsule of BCM-95 per day.</description>
    <arm_group_label>Trial</arm_group_label>
    <other_name>Bio-Curcumin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Consuming 1 placebo capsule per day</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - BMI &gt; 25 kg/m2.

        Exclusion Criteria:

          -  having chronic inflammatory or autoimmune disease, gastrointestinal complaints or
             known biliary obstruction (past and present)

          -  use of anti-inflammatory drugs 2 weeks before the start of the study

          -  use of antibiotics during the 12 weeks preceding the trial

          -  pregnancy

          -  lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 30, 2017</study_first_submitted>
  <study_first_submitted_qc>October 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>October 30, 2017</last_update_submitted>
  <last_update_submitted_qc>October 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Glasgow</investigator_affiliation>
    <investigator_full_name>Emilie Combet</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>Endotoxaemia, Curcumin.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Endotoxemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Curcumin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

